Treace Medical Concepts TMCI
NASDAQ TMCI
$4.53 -0.10 (-2.16%)
As of: Sep 9, 2026 · 3:59 PM EDT

Treace Medical Concepts (TMCI) Total Debt Growth (3y) (2023 - 2026)

Analysis

Treace Medical Concepts (TMCI) Total Debt Growth (3y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 24.63%
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 4.06%
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 4.89%
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 11.72%
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 0.11%
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 252.76%
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn -10.56%
10 Treace Medical Concepts 312.82 Mn 267.20 Mn 35.61 Mn 5.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.68%
Mar 31, 2026 4.00%
Dec 31, 2025 3.87%
Sep 30, 2025 2.77%
Jun 30, 2025 1.94%
Mar 31, 2025 22.05%
Dec 31, 2024 21.99%
Sep 30, 2024 21.99%
Jun 30, 2024 22.00%
Mar 31, 2024 22.00%
Dec 31, 2023 19.61%